Events Database

263 historical macro events · 2010–today

Filtered by:pharmaceuticals industry✕ clear
DateEvent
Jul 12, 12Repeal of Obamacare: House Republicans' empty gesture
Jul 11, 12UK to ban export of drug approved for use in US executions
Jul 10, 12What to do about the growing menace of adverse drug reactions
Jul 8, 12Banks, drugmakers and arms dealers are the new face of our piratical past
Jul 8, 12Pharma overtakes arms industry to top the league of misbehaviour
Jul 5, 12GlaxoSmithKline: former chairman denies knowledge of $3bn US deal
Jul 4, 12GlaxoSmithKline's bribes are evidence that Big Pharma isn't working
Jul 3, 12GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales
Jul 3, 12Unified Patent Court split between Paris, London and Munich
Jun 24, 12Does Walgreens' deal for Boots prove private equity is the best medicine?
Jun 23, 12Drug shortages posing threat to health of seriously ill patients
Jun 21, 12The bipolar explosion
Jun 20, 12Pharmacy chain Walgreen takes 45% stake in Alliance Boots
Jun 19, 12Andy Hornby takes third job since leaving HBOS
Jun 13, 12Rich countries' $4bn pledge will immunise 62 million children
Jun 12, 12Pharmacists must put care before commerce
Jun 9, 12Greek debt crisis: chronic drug shortage risking lives of the sick
Jun 8, 12GlaxoSmithKline extends tender offer for Human Genome Sciences
May 24, 12GlaxoSmithKline and AstraZeneca invest in antibiotic research
May 18, 12Shareholder spring is offering even more sport than usual
May 15, 12Exporting medicines for profit puts British patients at risk, say MPs
May 10, 12GlaxoSmithKline turns up the heat on Human Genome Sciences
May 9, 12GlaxoSmithKline steps up hostile bid for Human Genome Sciences
May 6, 12Blindness prevention drug could save NHS £84.5m, trial results show
May 4, 12Shareholder rebels with a cause
Apr 27, 12Drug company attacks Nice for rejecting new lupus treatment
Apr 27, 12AstraZeneca boss David Brennan quits under pressure from investors
Apr 26, 12AstraZeneca: What the analysts say
Apr 26, 12David Brennan's successor faces unenviable task at AstraZeneca
Apr 25, 12GlaxoSmithKline shares slide after disappointing first quarter
Showing 3160 of 263